NCS Testing Technology Co., Ltd. (SHE:300797)
China · Delayed Price · Currency is CNY 17.73
-0.45 (-2.48%)
Feb 13, 2026, 3:04 PM CST
NCS Testing Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 1,182 | 1,098 | 949.53 | 815.42 | 701.64 | 585.46 | |
Revenue Growth (YoY) | 12.80% | 15.60% | 16.45% | 16.22% | 19.84% | 7.14% |
Cost of Revenue | 625.74 | 588.65 | 507.41 | 436.65 | 382.83 | 332.78 |
Gross Profit | 555.95 | 509.02 | 442.13 | 378.77 | 318.8 | 252.67 |
Selling, General & Admin | 291.18 | 277.2 | 253.57 | 208.79 | 186.02 | 146.13 |
Research & Development | 149.89 | 130.29 | 102.61 | 101.34 | 59.31 | 44.4 |
Other Operating Expenses | -9.49 | -0.09 | -2.59 | -0.21 | -24.31 | 3.05 |
Operating Expenses | 439.43 | 415.13 | 358.34 | 315.83 | 224.01 | 201.44 |
Operating Income | 116.52 | 93.89 | 83.78 | 62.94 | 94.79 | 51.24 |
Interest Expense | -5.58 | -5.51 | -5.94 | -6.55 | -7.21 | - |
Interest & Investment Income | 1.08 | 1.38 | 3.19 | 1.42 | 1.06 | 1.17 |
Currency Exchange Gain (Loss) | -1.08 | -1.08 | -0.11 | 0.21 | -0.46 | 0.09 |
Other Non Operating Income (Expenses) | 2.95 | 0.8 | -2.04 | -0.95 | 3.18 | -0.19 |
EBT Excluding Unusual Items | 113.89 | 89.49 | 78.89 | 57.06 | 91.36 | 52.3 |
Gain (Loss) on Sale of Investments | -0.29 | -0.38 | -0.26 | -0.26 | -0.14 | -0.1 |
Gain (Loss) on Sale of Assets | 0.16 | 0.17 | - | 15.79 | - | 0.04 |
Asset Writedown | -0.19 | -0.08 | -0.42 | -1.58 | -0.37 | -0.9 |
Other Unusual Items | 40.05 | 41.03 | 25.88 | 24.13 | - | 35.38 |
Pretax Income | 153.62 | 130.24 | 104.1 | 95.14 | 90.85 | 86.73 |
Income Tax Expense | 11.92 | 8.94 | 3.18 | 1.33 | 6.68 | 9.58 |
Earnings From Continuing Operations | 141.71 | 121.3 | 100.92 | 93.81 | 84.17 | 77.15 |
Minority Interest in Earnings | 16.38 | 23.72 | 24.78 | 20.04 | 0.02 | 0.07 |
Net Income | 158.09 | 145.02 | 125.7 | 113.84 | 84.19 | 77.22 |
Net Income to Common | 158.09 | 145.02 | 125.7 | 113.84 | 84.19 | 77.22 |
Net Income Growth | 21.13% | 15.37% | 10.41% | 35.22% | 9.03% | 11.69% |
Shares Outstanding (Basic) | 376 | 376 | 375 | 372 | 372 | 372 |
Shares Outstanding (Diluted) | 377 | 376 | 376 | 373 | 372 | 372 |
Shares Change (YoY) | -0.09% | -0.02% | 0.89% | 0.21% | 0.01% | 26.34% |
EPS (Basic) | 0.42 | 0.39 | 0.34 | 0.31 | 0.23 | 0.21 |
EPS (Diluted) | 0.42 | 0.39 | 0.33 | 0.31 | 0.23 | 0.21 |
EPS Growth | 21.23% | 15.39% | 9.44% | 34.94% | 9.02% | -11.59% |
Free Cash Flow | 44.42 | -14.36 | -69.26 | -63.56 | -22.74 | 30.63 |
Free Cash Flow Per Share | 0.12 | -0.04 | -0.18 | -0.17 | -0.06 | 0.08 |
Dividend Per Share | 0.120 | 0.120 | 0.100 | 0.089 | 0.068 | 0.021 |
Dividend Growth | 20.00% | 20.00% | 11.98% | 31.32% | 219.25% | 13.90% |
Gross Margin | 47.05% | 46.37% | 46.56% | 46.45% | 45.44% | 43.16% |
Operating Margin | 9.86% | 8.55% | 8.82% | 7.72% | 13.51% | 8.75% |
Profit Margin | 13.38% | 13.21% | 13.24% | 13.96% | 12.00% | 13.19% |
Free Cash Flow Margin | 3.76% | -1.31% | -7.29% | -7.79% | -3.24% | 5.23% |
EBITDA | 192.17 | 156.01 | 127.87 | 91.38 | 119.17 | 68.07 |
EBITDA Margin | 16.26% | 14.21% | 13.47% | 11.21% | 16.98% | 11.63% |
D&A For EBITDA | 75.65 | 62.12 | 44.09 | 28.44 | 24.38 | 16.83 |
EBIT | 116.52 | 93.89 | 83.78 | 62.94 | 94.79 | 51.24 |
EBIT Margin | 9.86% | 8.55% | 8.82% | 7.72% | 13.51% | 8.75% |
Effective Tax Rate | 7.76% | 6.86% | 3.06% | 1.40% | 7.35% | 11.04% |
Revenue as Reported | 1,182 | 1,098 | 949.53 | 815.42 | - | 585.46 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.